IN HET KORT: Federal Circuit zal Amgen's overwinning op blockbuster Enbrel-patenten niet opnieuw bezoeken – Reutersseptember 30, 2020
CBD Olie kan helpen bij artrose. Lees hoe op MHBioShop.com
Huile de CBD peut aider avec l’arthrose. Visite HuileCBD.be
The U.S. Court of Appeals for the Federal Circuit on Tuesday declined further review of a panel decision that blocked Novartis AG’s Sandoz unit from offering a biosimilar of Amgen’s arthritis drug Enbrel (etanercept) until 2029.
The Federal Circuit offered no comment in its per curiam order upholding the win for Amgen, which was represented by Sidley Austin. No dissents were noted, even though the panel split 2-1 in July.
To read the full story on Westlaw Today, click here: bit.ly/34eJmnk